-
1
-
-
0009395395
-
Perianal tumours
-
(Withrow SJ and MacEwen EG, eds). Philadelphia, PA: WB Saunders Co.
-
Withrow SJ: Perianal tumours. In: Small Animal Clinical Oncology (Withrow SJ and MacEwen EG, eds). Philadelphia, PA: WB Saunders Co. 1996, pp. 261-267.
-
(1996)
Small Animal Clinical Oncology
, pp. 261-267
-
-
Withrow, S.J.1
-
2
-
-
17444403045
-
Tumors of the skin and subcutis, perianal (hepatoid) gland tumors
-
(Morrison WB, ed). Baltimore, Williams & Wilkins
-
Thomas RC and Fox LE: Tumors of the skin and subcutis, perianal (hepatoid) gland tumors. In: Cancer in Dogs and Cats (Morrison WB, ed). Baltimore, Williams & Wilkins 1998, pp. 497-498.
-
(1998)
Cancer in Dogs and Cats
, pp. 497-498
-
-
Thomas, R.C.1
Fox, L.E.2
-
3
-
-
0029126687
-
Biomedical applications of electric pulses with special emphasis on antitumour electrochemotherapy
-
Mir LM, Orlowski S, Belehradek JJr, Tessie J, Rols MP, Sersa G, Miklavcic D, Gilbert R and Heller R: Biomedical applications of electric pulses with special emphasis on antitumour electrochemotherapy. Bioelectrochem Bioenerg 38: 203-207, 1995.
-
(1995)
Bioelectrochem Bioenerg
, vol.38
, pp. 203-207
-
-
Mir, L.M.1
Orlowski, S.2
Belehradek Jr., J.3
Tessie, J.4
Rols, M.P.5
Sersa, G.6
Miklavcic, D.7
Gilbert, R.8
Heller, R.9
-
4
-
-
0342886284
-
Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin
-
Cemazar M, Miklavcic D, Scancar J, Dolzan V, Golouh R and Sersa G: Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79: 1386-1391, 1999.
-
(1999)
Br J Cancer
, vol.79
, pp. 1386-1391
-
-
Cemazar, M.1
Miklavcic, D.2
Scancar, J.3
Dolzan, V.4
Golouh, R.5
Sersa, G.6
-
5
-
-
0029099862
-
Antitumour effectivness of electrochemotherapy with cisdiamminedichloroplatinum (II) in mice
-
Sersa G, Cemazar M and Miklavcic D: Antitumour effectivness of electrochemotherapy with cisdiamminedichloroplatinum (II) in mice. Cancer Res 55: 3450-3455, 1995.
-
(1995)
Cancer Res
, vol.55
, pp. 3450-3455
-
-
Sersa, G.1
Cemazar, M.2
Miklavcic, D.3
-
6
-
-
0031776828
-
Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy
-
Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, Miklavcic D, Jaroszeski MJ, Orlowski S, Reinigen DS, Rudolf Z, Belehradek M, Gilbert R, Rols MP, Belehradek J Jr, Bachaud JM, DeConti R, Stabuc B, Cemazar M, Coninx P and Heller R: Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br J Cancer 77: 2336-2342, 1998.
-
(1998)
Br J Cancer
, vol.77
, pp. 2336-2342
-
-
Mir, L.M.1
Glass, L.F.2
Sersa, G.3
Teissie, J.4
Domenge, C.5
Miklavcic, D.6
Jaroszeski, M.J.7
Orlowski, S.8
Reinigen, D.S.9
Rudolf, Z.10
Belehradek, M.11
Gilbert, R.12
Rols, M.P.13
Belehradek Jr., J.14
Bachaud, J.M.15
DeConti, R.16
Stabuc, B.17
Cemazar, M.18
Coninx, P.19
Heller, R.20
more..
-
7
-
-
0032126313
-
Electrochemotherapy with cisplatin: Potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients
-
Sersa G, Stabuc B, Cemazar M, Jancar B, Miklavcic D and Rudolf Z: Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer 34: 1213-1218, 1998.
-
(1998)
Eur J Cancer
, vol.34
, pp. 1213-1218
-
-
Sersa, G.1
Stabuc, B.2
Cemazar, M.3
Jancar, B.4
Miklavcic, D.5
Rudolf, Z.6
-
8
-
-
0034059465
-
Electrochemotherapy with cisplatin: Clinical experience in malignant melanoma patients
-
Sersa G, Stabuc B, Cemazar M, Miklavcic D and Rudolf Z: Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. Clin Cancer Res 6: 863-867, 2000.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 863-867
-
-
Sersa, G.1
Stabuc, B.2
Cemazar, M.3
Miklavcic, D.4
Rudolf, Z.5
-
9
-
-
0035150467
-
Electrochemotherapy: Potentation of local antitumour effectivness of cisplatin in dogs and cats
-
Tozon N, Sersa G and Cemazar M: Electrochemotherapy: Potentation of local antitumour effectivness of cisplatin in dogs and cats. Anticancer Res 21: 2483-2486, 2001.
-
(2001)
Anticancer Res
, vol.21
, pp. 2483-2486
-
-
Tozon, N.1
Sersa, G.2
Cemazar, M.3
-
10
-
-
0030690094
-
First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy
-
Mir LM, Devauchelle P, Quintin-Colonna F, Delisle F, Doliger S, Fradelizi D, Belehradek J and Orlowski S: First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76: 1617-1622, 1997.
-
(1997)
Br J Cancer
, vol.76
, pp. 1617-1622
-
-
Mir, L.M.1
Devauchelle, P.2
Quintin-Colonna, F.3
Delisle, F.4
Doliger, S.5
Fradelizi, D.6
Belehradek, J.7
Orlowski, S.8
-
11
-
-
0036150087
-
Electrochemotherapy of horses. A preliminary clinical report
-
Rols MP, Tamzali Y and Teissie J: Electrochemotherapy of horses. A preliminary clinical report. Bioelectrochemistry 55: 101-105, 2002.
-
(2002)
Bioelectrochemistry
, vol.55
, pp. 101-105
-
-
Rols, M.P.1
Tamzali, Y.2
Teissie, J.3
-
12
-
-
1242314664
-
Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of electric pulses
-
Spugnini EP and Porrello A: Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of electric pulses. J Exp Clin Cancer Res 22: 571-80, 2003.
-
(2003)
J Exp Clin Cancer Res
, vol.22
, pp. 571-580
-
-
Spugnini, E.P.1
Porrello, A.2
-
14
-
-
0011298457
-
Principles of treating chemotherapy complication
-
(Morrison WB, ed). Baltimore, Williams & Wilkins
-
Morrison WB: Principles of treating chemotherapy complication. In: Cancer in Dogs and Cats (Morrison WB, ed). Baltimore, Williams & Wilkins 1998, pp. 387-397.
-
(1998)
Cancer in Dogs and Cats
, pp. 387-397
-
-
Morrison, W.B.1
-
16
-
-
0023839382
-
Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system
-
Begg AC, Bartelink H, Stewart FA, Brown DM and Luck EE: Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system. NCI Monogr 6: 133-136, 1988.
-
(1988)
NCI Monogr
, vol.6
, pp. 133-136
-
-
Begg, A.C.1
Bartelink, H.2
Stewart, F.A.3
Brown, D.M.4
Luck, E.E.5
-
17
-
-
0031870747
-
Intratumoral cisplatin administration in electroehemotherapy: Antitumor effectiveness, sequence dependence and platinum content
-
Cemazar M, Milacic R, Miklavcic D, Dolzan V and Sersa G: Intratumoral cisplatin administration in electroehemotherapy: antitumor effectiveness, sequence dependence and platinum content. Anticancer Drugs 9: 525-530, 1998.
-
(1998)
Anticancer Drugs
, vol.9
, pp. 525-530
-
-
Cemazar, M.1
Milacic, R.2
Miklavcic, D.3
Dolzan, V.4
Sersa, G.5
-
18
-
-
0025976384
-
Intratumoral administration of cisplatin in slow-release devices. II. Pharmacokinetics and intratumoral distribution
-
Deurloo MJ, Kop W, van Tellingen O, Bartelink H and Begg AC: Intratumoral administration of cisplatin in slow-release devices. II. Pharmacokinetics and intratumoral distribution. Cancer Chemother Pharmacol 27: 347-353, 1991.
-
(1991)
Cancer Chemother Pharmacol
, vol.27
, pp. 347-353
-
-
Deurloo, M.J.1
Kop, W.2
Van Tellingen, O.3
Bartelink, H.4
Begg, A.C.5
-
19
-
-
0027300968
-
Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro
-
Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D and Howell SB: Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45: 2079-2085, 1993.
-
(1993)
Biochem Pharmacol
, vol.45
, pp. 2079-2085
-
-
Jekunen, A.P.1
Shalinsky, D.R.2
Hom, D.K.3
Albright, K.D.4
Heath, D.5
Howell, S.B.6
-
20
-
-
0029914460
-
Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity
-
Kuang L, Yang DJ, Inoue T, Liu WC, Wallace S and Wright KC. Percutaneous intratumoral injection of cisplatin microspheres in tumor-bearing rats to diminish acute nephrotoxicity. Anti-Cancer Drugs 7: 220-227, 1996.
-
(1996)
Anti-Cancer Drugs
, vol.7
, pp. 220-227
-
-
Kuang, L.1
Yang, D.J.2
Inoue, T.3
Liu, W.C.4
Wallace, S.5
Wright, K.C.6
-
21
-
-
0028219320
-
Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice
-
Landrito JE, Yoshiga K, Sakurai K and Takada K: Effects of intralesional injection of cisplatin on squamous cell carcinoma and normal tissue of mice. Anticancer Res 14: 113-118, 1994.
-
(1994)
Anticancer Res
, vol.14
, pp. 113-118
-
-
Landrito, J.E.1
Yoshiga, K.2
Sakurai, K.3
Takada, K.4
-
22
-
-
0029615394
-
Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of a human pancreatic cancer xenografts
-
Smith JP, Stock E, Orenberg EK, Yu NY, Kanekal S and Brown DM: Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of a human pancreatic cancer xenografts. Anti-Cancer Drugs 6: 717-726, 1995.
-
(1995)
Anti-Cancer Drugs
, vol.6
, pp. 717-726
-
-
Smith, J.P.1
Stock, E.2
Orenberg, E.K.3
Yu, N.Y.4
Kanekal, S.5
Brown, D.M.6
-
23
-
-
0023948639
-
Liposomes as a drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution
-
Steerenberg PA, Storm G, de Groot G, Claessen A, Bergers JJ, Franken MA, van Hoesel QG, Wubs KL and de Jong WH: Liposomes as a drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution. Cancer Chemother Pharmacol 21: 299-307, 1988.
-
(1988)
Cancer Chemother Pharmacol
, vol.21
, pp. 299-307
-
-
Steerenberg, P.A.1
Storm, G.2
De Groot, G.3
Claessen, A.4
Bergers, J.J.5
Franken, M.A.6
Van Hoesel, Q.G.7
Wubs, K.L.8
De Jong, W.H.9
-
24
-
-
0026767045
-
Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1, 2-diamminecyclohexaneplatinum (II) and cisplatin given i.v. and Ip. in the rat
-
Vadiei K, Siddik ZH, Khokhar AR, al-Baker S, Sampedro F and Perez-Soler R: Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2- diamminecyclohexaneplatinum (II) and cisplatin given i.v. and Ip. in the rat. Cancer Chemother Pharmacol 30: 365-369, 1992.
-
(1992)
Cancer Chemother Pharmacol
, vol.30
, pp. 365-369
-
-
Vadiei, K.1
Siddik, Z.H.2
Khokhar, A.R.3
Al-Baker, S.4
Sampedro, F.5
Perez-Soler, R.6
-
25
-
-
0347184816
-
Electrochemotherapy: Advantages and drawbacks in treatment of cancer patients
-
Sersa G, Cemazar M and Rudolf Z: Electrochemotherapy: advantages and drawbacks in treatment of cancer patients. Cancer Ther 1: 133-142, 2003.
-
(2003)
Cancer Ther
, vol.1
, pp. 133-142
-
-
Sersa, G.1
Cemazar, M.2
Rudolf, Z.3
|